Figure 11. Downregulation of SLCO1B3 inhibited the proliferation, migration, and invasion of BLCA cells. (A, B) Differential analysis and survival analysis of SLCO1B3. (C) The mRNA expression of SLCO1B3 in BLCA cells and normal bladder cells. (D, E) The knockdown efficiency of SLCO1B3 was confirmed by qRT–PCR and western blotting. (F, G) CCK-8 and EdU assay for the proliferation ability. (H) Wound healing assay for the migration ability. (I) Transwell assay for the invasion ability. *P < 0.05, **P < 0.01.